Protease inhibitors work against HIV-1 subtype C.
D000349:Africa / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use; D002585:Cesarean Section; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000494:pharmacology*; D015497:HIV-1 / Q000145:classification / Q000187:drug effects*; D006297:Health Services Accessibility; D020010:Heterosexuality; D006801:Humans; D007194:India / Q000453:epidemiology; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D015995:Prevalence; D015215:Zidovudine / Q000191:economics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D015215:Zidovudine